Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Double-blind Phase	STARTED	Momelotinib (MMB)	215
Double-blind Phase	STARTED	Ruxolitinib (RUX)	217
Double-blind Phase	STARTED	MMB to MMB	0
Double-blind Phase	STARTED	RUX to MMB	0
Double-blind Phase	COMPLETED	Momelotinib (MMB)	188
Double-blind Phase	COMPLETED	Ruxolitinib (RUX)	208
Double-blind Phase	COMPLETED	MMB to MMB	0
Double-blind Phase	COMPLETED	RUX to MMB	0
Double-blind Phase	NOT COMPLETED	Momelotinib (MMB)	27
Double-blind Phase	NOT COMPLETED	Ruxolitinib (RUX)	9
Double-blind Phase	NOT COMPLETED	MMB to MMB	0
Double-blind Phase	NOT COMPLETED	RUX to MMB	0
Open-label Phase	STARTED	Momelotinib (MMB)	0
Open-label Phase	STARTED	Ruxolitinib (RUX)	0
Open-label Phase	STARTED	MMB to MMB	171
Open-label Phase	STARTED	RUX to MMB	197
Open-label Phase	COMPLETED	Momelotinib (MMB)	0
Open-label Phase	COMPLETED	Ruxolitinib (RUX)	0
Open-label Phase	COMPLETED	MMB to MMB	1
Open-label Phase	COMPLETED	RUX to MMB	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01969838/flow